Dr. Martens shareholders approve all resolutions at annual meeting

Published 10/07/2025, 11:02
Dr. Martens shareholders approve all resolutions at annual meeting

LONDON - Dr. Martens PLC (LSE:DOCS) announced on Thursday that shareholders approved all 22 resolutions presented at its Annual General Meeting, with most measures receiving overwhelming support.

The iconic British footwear maker reported that all proposed resolutions passed with significant majorities. The final dividend received near-unanimous approval with 100% of votes cast in favor, while the company’s annual report and accounts were similarly endorsed with 100% support.

Among the key approved measures were the election of new board members Ije Nwokorie and Benoit Vauchy, who received 90.49% and 90.36% of votes respectively. Robert Hanson was elected with 99.98% support.

Shareholders also approved the removal of the 5% dilution limit for discretionary share plans with 99.87% of votes in favor. The reappointment of PricewaterhouseCoopers LLP as the company’s auditor passed with 99.99% support.

Special resolutions authorizing the general disapplication of pre-emption rights and additional disapplication of pre-emption rights were approved with 94.86% and 94.74% of votes respectively. The authorization for the company to purchase its own shares received 98.19% support.

The meeting saw strong shareholder participation, with 81.38% of the company’s voting capital represented for most resolutions.

Dr. Martens, founded in 1960, operates in over 60 countries and employs more than 3,650 people worldwide. The company sells its products through both direct-to-consumer and wholesale channels.

This article is based on a press release statement from Dr. Martens PLC.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.